Yen-Ling Chen, PhD
Assistant VP of New Drug Development
TaiRx, Inc.
Dr. Yen-Ling Chen is the Assistant Vice President of New Drug Development at TaiRx, Inc., with over ten years of experience in the biopharmaceutical industry. She has a robust track record in advancing drug candidates from preclinical research through Phase I-III clinical development.
At TaiRx, Dr. Chen has played a key role in steering a first-in-class oncology NCE into Phase II trials and advancing a sepsis program into Phase III. She also successfully managed the NDA submission and commercial launch of a nutrient supplement in the Taiwan market. Her core expertise includes strategic project management, clinical trial coordination, and regulatory filings with the US FDA, TFDA, and NMPA.
Dr. Chen holds her Ph.D. in Biochemistry and Molecular Biology from the College of Medicine, National Taiwan University. She is committed to leveraging her integrated technical and regulatory expertise to accelerate the development of innovative therapies.
Sessions
-
22-Jun-2026Theater 2TaiRx, Inc.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}